Home › NDC Lookup › RxCUI directory › RxCUI 237371

Sodium acetate 2 MEQ/ML Injectable Solution — RxCUI 237371

RxNorm drug concept · Semantic clinical drug
RxCUI 237371 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI237371
Official nameSodium acetate 2 MEQ/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium acetate 164 MG per 1 ML Injectable Solution
FDA products mapped11
Package NDCs mapped13
Reported Medicaid activity (SDUD)17,069 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sodium Acetate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used in a hospital or clinical setting to raise sodium levels in patients whose sodium has dropped too low — a condition called hyponatremia. This usually happens when someone...
  • What is Sodium Acetate Injection actually used for?
  • Neither, exactly. It's given through an IV line directly into a vein, but only after it's been carefully diluted by pharmacy staff into a larger bag of IV fluid. It's never injecte...
  • How is this medication given — do I swallow it or get a shot?
📖 Read our full Sodium Acetate guide →

🕸️ Concept Web — How Sodium acetate 2 MEQ/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sodium acetate 2 MEQ/ML Injectable Solution RxCUI 237371

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sodium acetate 56443
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sodium acetate Injectable Solution 373892
    • Sodium acetate Injectable Product 1158767
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sodium acetate 2 MEQ/ML 316677

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium acetate 2 MEQ/ML SCDC · 316677
  • Sodium acetate Injectable Solution SCDF · 373892
  • Sodium acetate Injectable Product SCDG · 1158767

📦 FDA Products & Package NDCs

11 products · 13 package NDCs
13 package NDCs map to RxCUI 237371 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00409-3299-05 25 VIAL in 1 TRAY (0409-3299-05) / 50 mL in 1 VIAL (0409-32... Sodium Acetate Hospira, Inc. 2005-05-16
00409-3299-06 25 VIAL in 1 CASE (0409-3299-06) / 100 mL in 1 VIAL (0409-3... Sodium Acetate Hospira, Inc. 2005-04-30
00409-3299-25 25 VIAL in 1 CASE (0409-3299-25) / 100 mL in 1 VIAL (0409-3... Sodium Acetate Hospira, Inc. 2013-11-19
00409-3299-26 25 VIAL in 1 TRAY (0409-3299-26) / 50 mL in 1 VIAL (0409-32... Sodium Acetate Hospira, Inc. 2013-11-19
00641-6262-01 1 VIAL in 1 CARTON (0641-6262-01) / 50 mL in 1 VIAL Sodium Acetate Hikma Pharmaceuticals USA Inc. 2024-05-20
00641-6263-10 10 VIAL in 1 CARTON (0641-6263-10) / 100 mL in 1 VIAL (0641... Sodium Acetate Hikma Pharmaceuticals USA Inc. 2024-05-20
70069-0047-25 25 VIAL, GLASS in 1 CARTON (70069-047-25) / 50 mL in 1 VIAL... Sodium acetate anhydrous Somerset Therapeutics, LLC 2025-10-23
70069-0048-20 20 VIAL, GLASS in 1 CARTON (70069-048-20) / 100 mL in 1 VIA... Sodium acetate anhydrous Somerset Therapeutics, LLC 2025-10-23
71357-0007-10 10 VIAL, PHARMACY BULK PACKAGE in 1 CASE (71357-007-10) / 5... Sodium Acetate MILLA PHARMACEUTICALS INC. 2024-10-25
71357-0008-10 10 VIAL, PHARMACY BULK PACKAGE in 1 CASE (71357-008-10) / 1... Sodium Acetate MILLA PHARMACEUTICALS INC. 2024-10-25
71357-0009-10 10 VIAL, PHARMACY BULK PACKAGE in 1 CASE (71357-009-10) / 1... Sodium Acetate MILLA PHARMACEUTICALS INC. 2024-12-06
80830-2436-02 25 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (80830-2436-2) /... SODIUM ACETATE Amneal Pharmaceuticals Private Limited 2025-08-12
80830-2437-02 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (80830-2437-2) /... SODIUM ACETATE Amneal Pharmaceuticals Private Limited 2025-08-12
Observed labelers: Hospira, Inc. (4) · MILLA PHARMACEUTICALS INC. (3) · Amneal Pharmaceuticals Private Limited (2) · Hikma Pharmaceuticals USA Inc. (2) · Somerset Therapeutics, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.